Log In
BCIQ
Print this Print this
 

Heartcel (formerly Allogeneic iMP cells)

  Manage Alerts
Collapse Summary General Information
Company Cell Therapy Ltd.
DescriptionAllogeneic immunomodulatory progenitor (iMP) cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase II
Standard IndicationHeart failure
Indication DetailsTreat advanced heart failure
Regulatory Designation
PartnerDaiichi Sankyo Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$17.9M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/10/2016

Undisclosed

$17.9M

Undisclosed

Get a free BioCentury trial today